(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TERAPIA ANTICÂNCER COMBINADA

ArquivadaInvention PatentPCT · EP2018058106

Application data

Number

112019016737

Type

Invention Patent

Filing

03/29/2018

Publication

03/31/2020

PCT

EP2018058106

Progress at the INPI

  1. Filing03/29/18
  2. Publication03/31/20
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 10/29/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

DE

See this company's full portfolio

Inventors

M. I. (pessoa física)

DE

M. R. (pessoa física)

DE

Technical data

Priority claims

EP

17164149.1 · 03/31/2017

EP

17197931.3 · 10/24/2017

Abstract

A presente invenção refere-se a terapias antineoplásicas que compreendem usar um mimético de SMAC em combinação com um antagonista de PD-1, cada um como descrito no presente documento.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

10/29/2024

RPI 2808

Parecer de pré-exame

#6.23

07/09/2024

RPI 2792

Adição na publicação

#15.35

10/13/2021

RPI 2649

Notificação de entrada na fase nacional - PCT

#1.3

03/31/2020

RPI 2569

Alteração de dados cadastrais

#1.1

08/20/2019

RPI 2537

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.